In an exclusive interview with The Defender, Dr. Danice Hertz said people like her who have been seriously injured by COVID vaccines are being dismissed or ignored, and because health officials won’t research their injuries and potential treatments, they have nowhere to turn.
During the Sept. 17 meeting of the FDA advisory panel to recommend whether to approve a third dose of Pfizer’s COVID vaccine, physicians pointed to data they said confirm the risks of Pfizer’s COVID vaccine don’t outweigh the benefits.
The 16 - 2 vote came after a sharp debate in which many of the panel’s independent experts, including infectious disease doctors and statisticians, challenged whether the data justified a broad rollout of extra shots when the vaccines appear to still offer robust protection against severe COVID-19 disease and hospitalization.
Over the last eight months of Joe Biden's tenure, everyone from public health officials, White House spokespeople, and cabinet secretaries have insisted that the federal government would not and could not mandate a vaccine for private citizens. Yet that's exactly what Biden announced he would direct the government to do.
Events this weekend showcased the intense bifurcation of America into two separate realities. As our country observed the 20th anniversary of the 9/11 attacks, former presidents gathered, sans Donald Trump, in New York for a solemn ceremony — wearing masks even though they are fully vaccinated and were outside.
Two active duty members of the U.S. Armed Forces on Aug. 17 filed a lawsuit against the U.S. Department of Defense, U.S. Food and Drug Administration and U.S. Department of Health and Human Services on behalf of themselves and 220,000 active service members who are being forced to get a COVID vaccine despite having had COVID and acquired natural immunity to SARS-CoV-2.
Defense Secretary Lloyd Austin issued a memo last week calling for the mandatory COVID-19 vaccinations of American troops. Austin ordered United States military leaders to "impose ambitious timelines for implementation."
Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.
